The global bone wax market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to augment the growth of the market during the forecast period include the rise in the global prevalence of sports and recreation-related injuries, orthopedic diseases, and accidental fracture cases, which leads to surgical procedures. Moreover, the increasing use of absorbable bone wax products in surgeries is also a primary factor that is boosting the growth of the market during the forecast period.
For instance, according to the National Safety Council (NSC) report, in 2017 about 526,000 were diagnosed with sports and recreation-related injuries and are expected to grow in the near future, which is expected to fuel the market growth. Bone wax is a sterile mixture of beeswax and isopropyl palmitate, a wax-softening agent used to control bleeding from bone surfaces during surgical operations that involve cutting through bones across surgeries such as orthopedics, thoracic surgery, neurosurgery, dental, traumatology, and maxillofacial surgeries. However, as in any material implanted inside the body tissues, bone wax may cause side effects, such as increased susceptibility to infection, which in turn, is expected to restrain the market growth.
Market Coverage
Competitive Landscape: Baxter International Inc, B. Braun Melsungen AG, Johnson & Johnson Services, Inc. Medtronic plc, and Abyrx Inc.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Bone Wax Market Report by Segment
By Product
• Absorbable Bone Wax
• Non-Absorbable Bone Wax
By Application
• Orthopedic Surgery
• Thoracic Surgery
• Neurosurgery
• Others
Global Bone Wax Market by Region
North America
Europe
Asia-Pacific
Rest of the World